Fig 2. Seizure outcome at 2–4 weeks and 6 months after immunotherapy initiation according to underlying neuronal antibody.
Left bar, seizure outcome at 2–4 weeks; right bar, seizure outcome at 6 months. Number: percentage of patients with seizure remission. Abbreviations: NMDAR, N-methyl-d-aspartate receptor; VGKC, voltage-gated potassium channel; GABAb, gamma aminobutyric acid b.
